Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705715 · ClinicalTrials.gov registry record · Phase 1
Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: a Dimensional Approach
A Phase 1 study of Neuropsychiatric Syndromes, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT03705715 is a Phase 1 study of Neuropsychiatric Syndromes that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03705715, a Phase 1 study of Neuropsychiatric Syndromes, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to determine whether there is more extensive inflammation in the brain of people with clinical evidence of neuropsychiatric syndromes, such as mood disorder, chronic pain syndrome, dementia, traumatic brain injury, or substance abuse. The research will also explore whether there is more inflammation in patients with more neuropsychiatric symptoms. Inflammation in the brain will identified by using Positron Emission Tomography (PET) with the radiotracer \[11C\]PBR-28 or \[11C\]ER176.
Conditions Studied
Interventions
- DRUG PET with radiotracer [11C]PBR-28 ( or [11C]ER176)
- OTHER Affective challenge
Study Locations (1)
Texas
- BBSB at UTHealth - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2028-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03705715
The ClinicalTrials.gov registry entry for NCT03705715 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuropsychiatric Syndromes appearing as the primary indexed condition, and to 2 interventions - of which PET with radiotracer [11C]PBR-28 ( or [11C]ER176) is the first listed.
NCT03705715 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03705715 about?
NCT03705715 is a clinical study titled "Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: a Dimensional Approach". The purpose of this research is to determine whether there is more extensive inflammation in the brain of people with clinical evidence of neuropsychiatric syndromes, such as mood disorder, chronic pain syndrome, dementia, traumatic brain injury, or substance abuse. The research will also explore wh...
What is the current status of trial NCT03705715?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2017-05-01. Estimated completion is 2028-08.
What conditions does trial NCT03705715 study?
This clinical trial studies the following conditions: Neuropsychiatric Syndromes.
What interventions are being tested in trial NCT03705715?
The interventions under investigation include: PET with radiotracer [11C]PBR-28 ( or [11C]ER176) (DRUG), Affective challenge (OTHER).
Who is sponsoring clinical trial NCT03705715?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03705715 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.